KoBioLabs, Inc. provides microbiome therapeutics for metabolic, immune, and neurological diseases. The company is based in Seoul, South Korea.
Stock data | 2024 | Change |
---|---|---|
Price | $3.65 | N/A |
Market Cap | $68.87M | N/A |
Shares Outstanding | 18.87M | N/A |
Employees | 52.00 | N/A |